![Jan Peter Olofsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Peter Olofsson
Fundador en
Redoxis AB
.
Perfil
Peter Olofsson is the founder of Redoxis AB, founded in 2007, holding the title of Director.
Dr. Olofsson is currently the Chief Executive Officer of ProNoxis AB since 2012.
Former positions include Principal at Biovitrum AB and Principal at Arexis AB. Education includes a doctorate from the University of Lund and an MBA from the University of Gothenburg.
Cargos activos de Jan Peter Olofsson
| Empresas | Cargo | Inicio |
|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Fundador | 01/01/2007 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Director Ejecutivo | - |
Antiguos cargos conocidos de Jan Peter Olofsson.
| Empresas | Cargo | Fin |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Director/Miembro de la Junta | 31/12/2009 |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formación de Jan Peter Olofsson.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
- Bolsa de valores
- Insiders
- Jan Peter Olofsson
